Reunion Neuroscience Inc. (REUN) Research

Field Trip Health Ltd. is a North American company specializing in the development and delivery of psychedelic-assisted therapies. The organization operates Field Trip Health Centres, which offer psychedelic-based treatments, and provides digital applications under the Field Trip brand. Additionally, its Field Trip Discovery division focuses on researching and creating next-generation psychedelic molecules. The company also administers ketamine-assisted therapy to address various conditions, including depression, anxiety, and addiction. Established in 2008, Field Trip Health Ltd. is based in Toronto, Canada.

Market snapshot

Symbol
REUN
Price
$1.12
Day change
-0.89%
Market cap
$16.6M
P/E ratio
-0.34x
52-week range
0.63-21.556
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Axcella Health Inc. (AXLA)
  • Celyad Oncology S.A. (CYAD)
  • Field Trip Health Ltd. (FTRP)
  • Gelesis Holdings, Inc. (GLS)
  • TuHURA Biosciences, Inc. (HURA)
  • Imunon, Inc. (IMNN)
  • Kineta, Inc. (KA)
  • Notable Labs, Ltd. (NTBL)

Open Reunion Neuroscience Inc. (REUN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.